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Aim: To investigate the degree by which epigenetic signatures in children from mothers with gestational
diabetes mellitus (GDM) are influenced by environmental factors. Methods: We profiled the DNA methy-
lation sihgnature of blood from lean, obese and GDM mothers and their respective newborns. Results:
DNA methylation profiles of mothers showed high similarity across groups, while newborns from GDM
mothers showed a marked distinct epigenetic profile compared with newborns of both lean and obese
mothers. Analysis of variance in DNA methylation levels between newborns showed higher variance in
the GDM group. Conclusion: Our results suggest that environmental factors, rather than direct transmis-
sion of epigenetic marks from the mother, are involved in establishing the epigenetic signature associated
with GDM.
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Pregnancy represents a critical window of development where nutritional and hormonal factors can have a major
influence on disease risk later in the life of the offspring. For instance, offspring born from mothers affected by
gestational diabetes mellitus (GDM) during pregnancy exhibit increased adiposity, adverse cardiometabolic risk
profile, higher incidence of Type II diabetes and earlier onset of puberty among girls [1,2]. This suggests that
factors in the extracellular milieu, such as hyperglycemia during fetal growth could determine metabolic health [3,4].
Recently, we showed that both maternal obesity and glycemia are determinants of increased early life adiposity,
with maternal GDM being more influential than maternal weight [5]. While genetic factors may be at play, studies
conducted in genetically identical animals indicate that environmental factors affect developmental programming
through the regulation of epigenetic signals [6,7].
Epigenetic signals include methylation of DNA, a covalent modification of DNA associated with altered tran-
scriptional activity, which regulates gene accessibility of the transcription machinery [8,9]. Epigenetic patterns
established during development thereby regulate gene expression and numerous fundamental embryonic processes
such as genomic imprinting, X inactivation and the regulation of cell lineage progression and tissue specificity [10,11].
Several studies have established an association betweenGDMand an altered epigenetic profile in the offspring [12–19].
Others have compared the epigenetic profile of placenta to that of cord blood of the infant [20,21].
Factors such as exercise, weight loss and dietary factors can acutely remodel the epigenome of metabolic cells
and tissues [22–27], providing evidence that DNA methylation is a dynamic process highly amenable to external
factors. A recent report that employed simulated and empirical data from the Dutch famine suggested that selection
of embryos by adverse environmental factors, and not dynamic DNA methylation changes, contribute to DNA
methylation signatures in the infant [28]. Further studies are thus warranted to investigate the respective contribution
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of gametic inheritance, selection of embryos and extracellular factors during development in setting altered DNA
methylation signatures observed in children born from mothers with GDM.
Here, we sought to compare the epigenetic profile of blood from mothers with GDM to that of their offspring
and gain insight into the nature of the transmission of epigenetic patterns from mother to offspring. We performed
reduced representation bisulfite sequencing (RRBS) in blood from eight lean, normal glucose tolerant (NGT)
women, eight women with obesity and eight women with GDM as well as their respective newborns. We confirmed
that DNAmethylation signatures of newborns fromGDMmothers are altered; however, no difference in epigenetic
signatures of the blood was found between lean mothers and mothers with obesity or GDM. Additionally, we report
an increased variance in DNA methylation between newborns of GDMmothers, compared with newborns of lean
and obese mothers. Our results suggest that a direct transmission of epigenetic marks from the mother is not
involved in establishing the epigenetic signature associated with GDM, but instead, supports that environmental
influences are at play.
Materials & methods
Ethical approval
The study was approved by the ethics committee at the University of Gothenburg (Dnr 402-08). All women
received oral and written information about the study and gave informed written consent before enrollment of
themselves and their children.
Subjects
As part of the pregnancy obesity nutrition child health (PONCH) study [5], lean (BMI 18.5–24.9 kg/m2) and
obese (BMI ≥30 kg/m2) pregnant women were recruited from six antenatal health units within the Gothenburg
area, and women with GDM (irrespective of BMI) were recruited at the Sahlgrenska University Hospital at time of
diagnosis. In Gothenburg at the time of the present study (2009–2015), all pregnant women had nonfasting blood
glucose measured regularly throughout pregnancy, and women with an elevated nonfasting glucose (>8 mmol/l)
underwent oral glucose tolerance tests, where they were diagnosed according to the European Association for the
Study of Diabetes 1991 criteria [29]. None of the women included in the present study received insulin or metformin
treatment. All women (in all three groups) were born in Sweden to parents of European ethnicity. Children included
in the study were divided into groups corresponding to the category assigned to their mother. Mode of delivery at
birth was vaginal delivery for all children apart from one child in the obese group and one in the GDM group that
were born by cesarean sections.
Maternal visits
Maternal pregnancy visits have been described previously [5]. These were all in the morning after an overnight fast,
and included anthropometric measurements, blood sampling and completion of life-style questionnaires. HbA1c,
C-reactive protein (CRP), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) and glucose levels
were analyzed at the accredited (SWEDAC ISO-15189; No.1240) Clinical Chemistry Laboratory, Sahlgrenska
University Hospital at weeks 35–37 (Trimester 3 [T3]). GDM women received standard obstetric hospital care
including diet and lifestyle advice. As GDM women did not attend study visits early in pregnancy, trimester one
weights were collected from medical records.
Infant anthropometric measurements
Infant anthropometric measurements have been previously described [5]. Birth-weight and length were collected
from medical records. Anthropometric and body composition measurements were made at visits at 1 week (4–
10 days) and 12 weeks (80–90 days) after birth, and anthropometric measurements at 52 weeks (355–375 days).
During the two first visits, weight, fat mass and fat-free mass were measured by air-displacement plethysmography
using a PEAPOD (software version 3.3.0; COSMED, Rome, Italy).
DNA isolation
Blood from mothers was taken from a fasting blood sample collected in T3. Blood from infants was sampled with
a neonatal heel prick 48 h after birth. Blood samples from both mother and infant were collected in EDTA tubes
and stored at -80◦C.
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Genomic DNA was extracted from whole blood using DNeasy Blood and Tissue Kit (QIAGEN, Hilden,
Germany) according to the manufacturer’s protocol. Yield and quality was assessed by Qubit dsDNA HS Assay Kit
(Thermo Fisher Scientific, Hvidovre, Denmark) and NanoDrop (Thermo Fisher Scientific).
Library preparation
Multiplexed RRBS was performed as previously described [23,24]. Briefly, genomic DNA was incubated with
Msp1 (NEB, Frankfurt, Germany) restriction enzyme overnight for fragmentation. Adenylation was performed
using dNTP (NEB) and Klenow fragment (NEB) followed by an AMpure Bead clean-up (Beckman Coulter,
Copenhagen, Denmark) and ligation to TruSeq adapters (Illumina, CA, USA). Twelve ligated samples were pooled
and subjected to bisulfite conversion using EZ DNA Methylation Kit (Zymo Research, Freiburg, Germany). The
library pool was amplified by PCR (2 min 95◦C [30 s 95◦C, 30 s 65◦C; 45 s 72◦C] × 20 cycles; 7 min 72◦C) with
PfuTurboHotstart DNA polymerase (Agilent, Glostrup, Denmark). PCR products were purified using the AMPure
Bead clean-up. Libraries were sequenced on a HiSeq 2500 (Illumina) at the Danish National High-Throughput
DNA Sequencing Centre, on an 81 bp single-end sequencing mode.
Data analysis
Differential methylation analysis
FASTQ files were preprocessed with Trim Galore using the –rrbs flag. Alignment and CpG coverage statistics
were computed using Bismark [30]. The missing values in CpG sites were kNN imputed for both methylation and
unmethylation matrix, separately [31]. Afterward, the CpG sites were aggregated into probe regions comprising a
minimum of 20 CpG sites, close to each other, no more than 100 bp in at least 95% of the samples by using
BiSeq [32]. SNPs and high coverage CpG sites were filtered out. A generalized linear model (y∼ 0+ group+ gender)
considering gender as a covariate was fit. The differentially methylated regions (DMRs) aggregated into gene and
promoters were identified by using edgeR comprising CpG probes with at least 100 counts for all samples [33]. DMR
analysis was performed for three different genomic regions: CpG probes; promoters (-1 to 2 kb from transcription
start site [TSS]); genes. Gene set enrichment analysis was performed using FRY [34].
Mean CpG probe methylation
Mother and newborn mean CpG probe methylation levels were compared by using pairwise Wilcoxon-test, across
individuals.
Correlation of CpG sites
CpG probe methylation levels across samples were correlated to each other by Pearson’s correlation. Correlation
between clinical parameters and DMRs was performed by using Spearman correlation. The p-values for each type
of correlation analysis were adjusted for multiple testing correction using Benjamini–Hochberg method [35].
Cell type deconvolution
Cell type deconvolution analysis requires a reference matrix and input matrix to be deconvoluted. BLUEPRINT [36]
epigenome consortium data were retrieved using DeepBlueR (Supplementary Table 4) [37]. Mean β-values for CpG
islands were used for generating the referencematrix for cell type deconvolution. The referencematrix was comprised
of B cell, CD14-positive monocyte, CD4-positive T cell, CD8-positive T cell, natural killer cell and neutrophils. To
identify the most informative CpG islands for the cell type deconvolution analysis, sparse PCA was performed on
the reference matrix and zero loadings on PC1 was removed from the reference matrix [38]. The final reference matrix
contained 4016 CpG islands (Supplementary Table 5). The kNN imputed methylation/unmethylation matrix was
used to generate the β-values and aggregated into CpG’s matching the genomic locations in the reference matrix.
Deconvolution analysis was performed by using Houseman method [39] and EpiDISH [40].
Data availability
The Gene Expression Omnibus (GEO) accession number for the DNA-methylation datasets is GSE128289.
Results
To study the influence of obesity and GDM on the transmission of DNA methylation patterns from mother to
newborn, we performed genome-wide DNA methylation analysis at single nucleotide resolution using RRBS (an
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Table 1. Clinical parameters of mothers, fathers and newborns.
Parameter Lean Obese GDM
N 8 8 8
Mothers
Age (years) 27.4 ± 3 29.4 ± 4 34.1 ± 3† ,‡
GDM diagnosis (days) 0 ± 0 0 ± 0 146 ± 65† ,‡
Prepregnancy BMI (kg/m2) 21 ± 2 35.1 ± 4† 27.3 ± 6† ,‡
Tri 3 BMI (kg/m2) 24.6 ± 2 38.9 ± 5† 30.5 ± 6† ,‡
Tri 3 gestational weight gain (kg) 11.8 ± 3 11 ± 4 7.3 ± 6
Tri 3 weight (kg) 68 ± 6 106.7 ± 14† 81.4 ± 12† ,‡
Tri 3 fat percentage (%) 30.9 ± 6 45.4 ± 6† 34.9 ± 6
Tri 3 HbA1c (mmol/mol) 28.4 ± 2 31.6 ± 2† 32.8 ± 3†
Tri 3 HOMA-IR 1.47 ± 1 4.09 ± 1† 2.23 ± 1
Tri 3 glucose (mmol/l) 4.67 ± 0 4.59 ± 0 4.45 ± 1
Tri 3 CRP (mg/l) 2.1 ± 1 7.5 ± 4† 5.1 ± 5
Tri 3 insulin (pmol/l) 7.3 ± 3 19.9 ± 7 10.6 ± 5
Tri 3 IGF-1 (μg/l) 241 ± 63 328 ± 98 270 ± 86
Tri 3 leptin (μg/l) 17.2 ± 14 53.9 ± 18† 21.5 ± 7‡
Tri 3 adiponectin (mg/l) 17.8 ± 13 10.1 ± 5† 17.9 ± 17‡
Tri 3 TSH (mIU/l) 1.89 ± 1 2.4 ± 2 1.59 ± 1
Tri 3 T4 (pmol/l) 12.99 ± 1 11.69 ± 2 13.25 ± 1
Tri 3 ferritin (μg/l) 15.7 ± 8 26.4 ± 21 23 ± 7
Tri 3 transferrin (μmol/l) 4.32 ± 1 3.84 ± 1 4.12 ± 1
Tri 3 cholesterol (mmol/l) 6.75 ± 1 6.14 ± 0 5.74 ± 1
Tri 3 HDL (mmol/l) 2.21 ± 1 1.85 ± 1 1.75 ± 0
Tri 3 LDL (mmol/l) 4.2 ± 1 3.69 ± 0 3.51 ± 1
Fathers
Age (years) 29.9 ± 4 31.3 ± 4 34.9 ± 3
BMI (kg/m2) 24.3 ± 4 25.3 ± 4 25.7 ± 2
Newborns
Males/total babies 2/8 7/8 4/8
Gestational age (weeks) 40.5 ± 0.7 41 ± 1 39.6 ± 1‡
Birth height (cm) 50.3 ± 1.3 51.6 ± 1.8 50.6 ± 1.2
Birth weight (kg) 3.7 ± 0.4 3.8 ± 0.4 3.6 ± 0.4
Birth BMI (kg/m2) 14.6 ± 1 14.1 ± 1.1 14.1 ± 1.3
Week 1 BMI (kg/m2) 14.5 ± 1.3 14 ± 1.3 14.6 ± 1.3
Week 1 fat mass (%) 14 ± 4.5 13.5 ± 4 14.3 ± 3.4
Week 1 fat free mass (%) 86 ± 4.5 86.5 ± 4 85.7 ± 3.4
Week 12 BMI (kg/m2) 17 ± 1.7 16.6 ± 0.9 16.7 ± 0.4
Week 12 fat mass (%) 24.3 ± 5 24.9 ± 2.6 29.1 ± 2
Week 12 fat free mass (%) 75.7 ± 5 75.1 ± 2.6 70.9 ± 2
Data are mean ± standard deviation from the cohort. Differences between groups was analyzed by one-way ANOVA and Turkey’s multiple comparisons test.
†p  0.05 versus Control subjects in same parameter.
‡p  0.05 versus Obese in same parameter.
CRP: C-reactive protein; GDM: Gestational diabetes mellitus; HDL: High-density lipoprotein; HOMA-IR: Homeostatic model assessment-insulin resistance; LDL: Low-density
lipoprotein; Tri: Trimester.
assay that targets DNA regions with a high CpG content) in blood from 24 mother–newborn pairs; eight lean,
NGTwomen, eight women with obesity and eight women with GDM (four newborn and onemother was excluded
due to low mapping efficiency [Supplementary Table 1]). Clinical characteristics of study participants are presented
in Table 1. To minimize the confounding effects of paternal inheritance, fathers of all groups were matched for
age and BMI (Table 1). Prepregnancy BMI were higher in both mothers from the Obese (35.1 kg/m2 ± 4) and
GDM group (27.3 kg/m2 ± 6), compared with Lean mothers (21 kg/m2 ± 2). Gestational weight gain was similar
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across groups, while HbA1c levels were higher in both Obese and GDM mothers. Glucose levels were controlled
by lifestyle treatment in the GDM mothers, and, consequently, insulin resistance, as measured by the homeostatic
model assessment (HOMA) insulin resistance (IR) method, was only higher in the Obese mothers (Table 1).
Newborns across groups were clinically homogeneous, except for shorter gestational age in GDM (Table 1).
Distinct epigenetic signatures in each mother–newborn pair
Initial investigation of DNAmethylation signatures in mother–newborn pairs by multidimensional scaling plotting
revealed that the largest separation was due to the sex of the newborn, which has been previously reported
(Supplementary Figure 1A) [13]. Including sex as a covariate corrected for the heavy sex distribution as visualized
on the multidimensional scaling plot (Figure 1A). Including sex as a covariate removed otherwise significantly
methylated regions on the X chromosome (Supplementary Table 2). Compared with mothers, mean CpG probe
methylation levels were lower in newborns, regardless of the group, while a tendency toward a higher methylation
in GDM newborns was observed, similar to a previous report (Figure 1B) [16]. At the genomic region level, DNA
methylation levels in newborns compared with mothers were lower for 181 regions in the Lean group, 113 in the
Obese group and 93 regions in the GDM group, while higher for only 25, 12 and 20 regions in Lean, Obese
and GDM, respectively (Supplementary Table 2). A larger overlap of DMRs was found between Lean and Obese
(72) compared with both Lean and GDM (50) and Obese and GDM (43) (Figure 1C). Together with a lower
correlation of maternal to newborn DNA methylation (Supplementary Figure 1B), the data suggest that GDM is
associated with an altered epigenetic variation between mothers and their respective babies, compared to Lean and
Obese.
Specific gene pathways are affected by obesity & GDM during pregnancy
To gain functional insight into the gene pathways differentially affected betweenmother and children, we performed
gene ontology analysis of the genes nearest to the DMRs found between mothers and their respective newborns.
We found that the majority of terms were common across groups and, noticeably, for hypomethylated regions,
numerous terms related to development such as ‘positive regulation of neuron projection development’, ‘in utero
embryonic development’ and ‘lymph vessel development’ (Figure 1D & Supplementary Table 3). Some terms were
only shared by one of two groups such as ‘neuron development’ and ‘cell differentiation’ (commonly hypomethylated
in the Lean and Obese groups), ‘response to nutrient levels’ (only hypomethylated in Obese group) and ‘positive
regulation of cholesterol efflux’ (only hypermethylated in the GDM group) (Figure 1D). These data reinforce that
the epigenetic pattern of children can be influenced by the presence of obesity or diabetes in the mother and further
suggest that altered epigenetic signature may affect particular biological processes.
Epigenetic signatures are not set by different cell type compositions
To control for the possibility that distinct epigenetic profiles werecaused by a remodeling of cell type composition
under each pregnancy state, we estimated cell type composition in each samples using a newly developed method
to deconvolutebased on blood cell type specific DNA methylation databases [39,40] and using either the Houseman
or EpiDISH methods. Both methods returned similar cell type compositions (Supplementary Figure 1C). Analysis
by the EpiDISH method revealed a clear difference between mothers and newborns, where mothers’ blood showed
higher counts for neutrophils, while newborns were more enriched for T lymphocytes (Figure 1E). Our results are
consistent with a previous study that performed direct cell type quantification by flow cytometry of infant and
adult blood samples [41]. Importantly, we did not observe any difference between groups (Figure 1E). Thus, our
data suggest that differences in DNA methylation between Lean, Obese and GDM groups are independent of
blood cell type composition.
The altered epigenome of GDM newborns may be caused by environmental influences
Next, we investigated whether the differences in DNA methylation that we detected between mother and newborn
pairs could be due to altered epigenetic patterns of mothers or newborns. Consistent with differential methylation
analysis, correlation analyses of DNA methylation levels between mothers and their respective newborn showed
higher associations in the Lean group compared with the Obese and GDM groups (Supplementary Figure 2A).
Comparing DNA methylation between mothers showed high association and no differential methylation across
groups (Supplementary Figure 2B & Supplementary Table 2). On the contrary, we found marked differences in
DNAmethylationwhen comparing newborns across groups, with 187DMRs (164 hypo- and 23 hyper-methylated)
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Figure 1. Distinct epigenetic signatures in each mother–newborn pair. (A) MDS plot of leading logFC dimension 1 and 2 of DNA
methylation data from whole blood samples removing data from sex chromosomes. (B) Box and whisper plot showing mean CpG
methylation levels in individual replicates from LE, OB and GDM across CpG probes. Pairwise Wilcoxon test was used to identify
relationships between mother and newborn methylation across groups. The p-values were adjusted for multiple testing correction using
Benjamini–Hochberg method. (C) Overlap of differential methylated regions of mother–newborn pairs of LE (green), OB (blue) and GDM
(red). (D) FRY pathway enrichment for GO biological processes of hypomethylated and hypermethylated genes associated with DMRs of
mother–newborn pairs of lean, obese and GDM. Gene ratio was reported as the size of dot and false discovery rate as color as indicated
in the legend. (E) Estimated cell populations proportions in β-value of individual samples between newborn and mother across groups
was calculated by EpiDISH.
DMR: Differentially methylated region; GDM: Gestational diabetes mellitus; GO: Gene ontology; LE: Lean; M: Mother; MDS:
Multidimensional scaling; N: Newborn; OB: Obese.
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in Lean compared with GDM, and 149 DMRs (125 hypo- and 24 hyper-methylated) comparing Obese to GDM,
but no differences between Lean and Obese (Supplementary Table 2 & Figure 2A). Of these DMRs, 73 regions
were common (63 hyper- and 10 hypo-methylated) between the comparisons GDM versus Lean and GDM versus
Obese (Figure 2B). These data, showing higher association in DNA methylation between mothers compared with
newborns, support the idea that a direct transmission of specific DNAmethylation signatures frommother to child,
without environmental influences, is not the main factor contributing to the distinct DNA methylation signature
found in GDM babies.
We sought to investigate if altered epigenetic signatures in GDM newborns were caused by an environmentally
driven epigenetic plasticity occurring throughout embryo development and after birth. Recent work suggests that
early selection of embryos may influence the nature of the epigenetic signatures of children and, according to such
hypothesis, early selection of embryos would lead to a changed variance in DNAmethylation in the next generation,
whereas epigenetic changes occurring during development and throughout life would drive specific gene expression
reprogramming without altering variance [28]. When investigating variance in DMRs in our cohort, we detected
higher variance in newbornGDM compared with Lean andObese newborns, but not in themothers of either group
(Figure 2C). Collectively, our results suggest that environmental factors influence the altered DNA methylation
signatures of GDM newborns, and that such signatures may be selected in the early phases of fertilization.
Specific pathways are associated with the altered DNA methylation in newborn with GDM
Ontology analysis of the genes nearest to the DMRs across newborns, returned enrichment for pathways mainly
common between Lean andObese such as cardiac muscle thin filament assembly for regions hypomethylated, whereas
regions with higher DNA methylation levels were enriched for toll signaling pathway and ATP biosynthetic process
(Figure 2D & Supplementary Table 3).
DNA methylation associations with phenotypical outcomes
To gain insight into the specific clinical factors in mothers that might affect the epigenome of newborns born
from GDM mothers, we investigated associations between differential DNA methylation in newborns and clinical
features of the mothers. Interestingly, we observed a correlation of five DMRs in newborns with maternal serum
values of CRP, HDL and LDL levels, whereas two regions correlated with infant BMI at birth and fat free mass/fat
mass at week 12 (Figure 3). We did not replicate these correlations in the mothers (Supplementary Figure 3).
On the contrary, we observed that maternal leptin and the phenotypic outcome of the infants correlated to the
DNA methylation in specific regions of the mothers (Supplementary Figure 3). These results indicate that DNA
methylation at specific regions may predict fat distribution at week 12 and support a role of circulating factors in
differentially setting DNA methylation in mothers and in newborns.
Discussion
In the current study, we compared DNA methylation signatures in blood from mothers with GDM or obesity
during pregnancy to that of their respective newborns. We identified that, compared with lean controls, the
mother–newborn pairs exhibiting the most differential methylation were from the GDM group. Comparison of
DNA methylation signatures in mothers across groups was strikingly similar, suggesting that the altered DNA
methylation signatures that we detected in newborns from mothers with GDM are not set by direct transmission,
but instead, they were environmentally influenced. The fact that newborns from GDM exhibited the most variance
in DNA methylation supports the idea that DNA methylation profiles results mostly from a selection of embryos
having a specific epigenome, rather than driven by dynamic epigenetic changes that occurred during in utero
development.
The association between DNA methylation signatures in children and the metabolic phenotype of the mother
has been investigated in several studies [12–14,20,21,42]. We compared our DNA methylation results to three studies
examining the role of GDM on DNA methylation in newborns (chosen because they had genome-wide data
publicly available) and found that some regions were commonly differentially methylated in two out of the three
studies [13,14,20]. The genomic regions found in common between the studies included: four genes common to
the comparisons between both Lean and GDM, and Obese and GDM newborns (ACADM, ABCC4, LENG8 and
MBD3L1), 21 genes common to only the comparison between Lean and GDM newborns (TMCO3, SMYD3,
ATG7, G3BP2, ILF3, UHRF1BP1, FGF2, C19orf60, UBTF, PDXK, CPT1B, ERF, TTC9, ZNF837, DLG4,
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Figure 2. Altered epigenome of gestational diabetes mellitus newborns. (A) Comparison of the β-methylation of CpGs in newborns of
LE and OB, LE and GDM, and OB and GDM. Red dots represent significant DMRs, faded blue show the smoothed density for CpG probes,
while dark blue points show single CpG probes away from dense regions. (B) Overlap of significant DMRs found between newborns of
LE versus GDM and OB versus GDM, represented as hypermethylated and hypomethylated DMRs. (C) Relationship between DNA
methylation and standard deviation (σ) for DMRs found between newborns of lean/obese and GDM. Grey line indicates 95% CI. (D) FRY
pathway enrichment for GO biological processes of hypomethylated (Hypo) and hypermethylated (Hyper) genes associated with DMRs by
comparisons of newborns between LE versus OB, LE versus GDM and OB versus GDM. Gene ratio was reported as the size of dot and false
discovery rate as color.
DMR: Differentially methylated region; GDM: Gestational diabetes mellitus; GO: Gene ontology; LE: Lean; N: Newborn; OB: Obese.
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Figure 3. Correlations between newborn β-methylation of promoters and clinical parameters. Correlations were performed using
Spearman correlation tests. The p-values are adjusted for multiple testing using Benjamini–Hochberg method.
CRP: C-reactive protein; GDM: Gestational diabetes mellitus; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; LE: Lean; OB:
Obese.
NAP1L4, QTRT1, SLFN11, NPC1, C1orf229 and FOXP1) and five genes common to only the comparison
between Obese and GDM newborns (GALK2, XRRA1, TMEM151B, KLF2 and DTNA).
On the contrary, we did not detect CpG sites in common between our study and the large Pregnancy and
Childhood Epigenetics (PACE) consortium study, where 86 sitesassociated with maternal BMI [42]. The number
of overlapping genes or DNA methylation regions is quite modest. Such lack of consistency may be caused by
the nature of the tissues investigated across studies, for example, either cord blood [13,14,20,21], placenta [12,14,20]
or whole blood (current study) [42]. It is also possible that the method used for determining DNA methylation
may be introducing some of the inconsistencies across studies. Methodological differences between the Infinium
HumanMethylation450 BeadChips array [12–14,20], pyrosequencing [21] and RRBS (current study) could introduce
bias toward distinct genomic regions at various resolution, leading to a discrepancy between studies.
Given that the epigenome is amenable to environmental factors, all the epigenetic marks that we detected in
newborns may not be stable throughout life and therefore, may not have any physiological or pathological effect.
The notion that most DNA methylation marks are maintained throughout life is suggested by several studies,
notably studies investigating DNA methylation signatures in obesity and GDM and which showed that epigenetic
signatures detected at birth persist in adolescence [42,43]. The PACE consortium identified that the majority (72
out of 86) of CpG sites that were differentially methylated at birth persist in adolescence [42]. Despite the evidence
for high maintenance of DNA methylation across life, we did not see any overlap in DNA methylation changes
comparing our data from GDM newborns and individuals at 12 years of age from another study [43]. As discussed
above, this discrepancy could be caused by cell type specificity or technical bias. Other studies showed that epigenetic
marks are under continuous influence of circulating factors throughout life [1–3]. Thus, further studies, using the
same technologies for detecting DNA methylation at the whole genome level, should be used at various ages in
the same individuals to identify epigenetic marks that are stable throughout life and those under lifestyle influence
after birth. Stable epigenetic marks after birth may or may not be stable in utero, and the marks that are under
environmental influence in utero but stable after birth represent candidate targets of interest for preventing the
effect of adverse developmental programming.
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The major finding in this study was that DNA methylation signatures were similar across mothers from the
lean, obese and GDM groups, while DNA methylation signatures were markedly distinct in newborns from GDM
mothers. Given our small sample size, our study may not be designed to detect the epigenetic marks that were
transmitted throughmaternal gametic inheritance. However, our results do not support that a direct transmission of
epigenetic marks from mother to offspring, through so-called epigenetic inheritance, is the main factor explain the
altered epigenetic signatures in GDM children. Instead, our data suggest that environmental factors are the main
contributors of altered DNA methylation signatures in GDM newborns. Environmentally influenced epigenetic
patterns can be set during embryo development, potentially by a selection of gametes or fertilized embryos harboring
specific epigenetic signatures [44]. Such selection may occur based on the gene expression capacity of the developing
embryo which, itself, is set by both genetic and epigenetic blueprints. Therefore, to study the effect on the in utero
environment versus selection of embryos, it has been postulated that genetic backgrounds should be taken into
consideration [6]. Here, the nature of the study design did not allow to correct for genetic influences. Given that
GDM has a strong genetic component, we cannot rule out that the epigenetic signature that we detect in offspring
from GDM mothers is not caused by selection of embryos of particular genetic makeup which would lead to
selection of specific epigenetic profiles. We found that the regions differentially methylated in GDM newborns
exhibit higher variance compared with newborns from the lean and the obese groups which, according to several
studies, suggests an effect of embryo selection, rather than dynamic epigenetic changes in utero or early after
birth [28,45]. Similarly, another study showed a tendency toward a higher variance in DNA methylation in GDM,
compared with NGT children (mean SD GDM: 0.081; mean SD NGT: 0.075) [20]. If such selection exists in
GDM, the clinical parameters specific to GDM which apply selective pressure to embryos remain to be identified.
The potential candidates, blood sugar, cholesterol and oxidative stress, which are elevated in gestational diabetes
have been implicated in dynamic DNA methylation changes in somatic cells [22,23,46]. In the present study, we
found that maternal markers at trimester three correlate with DNAmethylation at specific regions in the newborns,
namely, serum CRP (PGLYRP1, SCRT1 and XYLT2), HDL (ALK) and LDL (TMEM263). These results suggest
that a specificity of circulating factors in influencing DNA methylation in utero.
An alternative explanation for not finding DNAmethylation signatures that are directly transmitted frommother
to children could be the cell type heterogeneity between mother and infant blood samples [41]. Accumulating
evidence supports the view that cell type heterogeneity can bias the interpretation of DNA methylation results
by misleadingly associating a certain disease or trait to a specific epigenetic mark, while detection of a mark
may simply be the consequence of a differential presence of specific cell types each harboring distinct epigenetic
signatures [6]. The importance of adjusting for cell heterogeneity was shown previously in the context of GDM,
where methylation at only 86 out of 9044 CpG sites originally identified as linked to BMI survived correction for
cell-type heterogeneity [42]. In the current study, we did not find differences in cell type composition across mothers
or newborns, which does not support the idea that the altered DNA methylation signature in newborns from
GDM mothers, compared with obese or lean mothers, is driven by cell type composition. It is possible, however,
that slight changes in cell type composition occur in GDM mothers or newborns, thereby masking altered DNA
methylation that would be common between mother and newborn and, consequently, affecting our interpretation
of the lack of direct transmission from mother to child.
Conclusion
Our results provide insight into the association between gestational diabetes and the epigenetic signatures of the
newborn. Our genome-wide approach identified specific gene pathways that may undergo reprogramming by
DNAmethylation in newborn of mothers with GDM. If genetic factors are not at play, our computational analyses
support the idea that the extracellular milieu during pregnancy is the main factor driving epigenetic changes in
the offspring. The pathophysiological consequence of adverse in utero exposure on the epigenome remains to be
further investigated.
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Summary points
• Whole genome DNA methylation profiling of blood samples from lean, obese and gestational diabetes mellitus
(GDM) mothers, showed highly similar profiles across groups.
• Analysis of cell type composition between groups showed large differences in neutrophil and T cell composition
between mothers and newborns, but only minimal differences across groups.
• Methylation analysis of each mother–newborn pair revealed that epigenetic signatures of newborns from GDM
mothers were the most distinct of all the groups.
• Differentially methylated regions between mother–newborn pairs were enriched for genes controlling
cholesterol efflux, only in GDM.
• Newborns from GDM mothers have an altered epigenetic profile compared with newborns of both lean and
obese mothers.
• Differentially methylated regions in newborns of GDM showed increased variance, suggesting that selection of
embryos, rather than environmentally induced epigenetic changes are at play.
• Maternal serum C-reactive protein, high density lipoprotein and low density lipoprotein levels correlate with
DNA methylation levels at specific regions, suggesting a role for environmental factors in setting region specific
DNA methylation signatures.
• Low level of similarity between mothers and newborns of GDM suggests that environmental factors, rather than
direct transmission from mother to child, are involved in establishing the epigenetic signature associated with
maternal GDM.
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